Clene Inc CLNN
Stock price quote for Clene Inc, symbol CLNN, Nasdaq Stock Exchange.
Quote data is updated continously during trading hours.
|
Clene Inc Symbol: CLNN Exchange: NSDQ
|
| Most Recent Activity |
Activity Today |
Yearly Statistics |
|
|
|
|
All market data is delayed by 15 minutes.
Stock price quotations are updated continuously. Click reload to refresh this display.
[Daily],
[Weekly]
and [Monthly] stock price charts are available for Clene Inc
Most Recent HeadlinesMNA: Dec 20th, 2024, 03:48Length: 4235 Biomednewsbreaks - Clene Inc. (NASDAQ: CLNN) Secures $10 Million Debt Facility To Advance Neurodegenerative Disease TreatmentsMNA: Dec 20th, 2024, 02:10Length: 4235 Biomednewsbreaks - Clene Inc. (NASDAQ: CLNN) Secures $10 Million Debt Facility To Advance Neurodegenerative Disease TreatmentsMNA: Dec 20th, 2024, 00:33Length: 4235 Biomednewsbreaks - Clene Inc. (NASDAQ: CLNN) Secures $10 Million Debt Facility To Advance Neurodegenerative Disease TreatmentsNNW: Dec 19th, 2024, 10:39Length: 5704 BioMedNewsBreaks -- Clene Inc. (NASDAQ: CLNN) Secures $10 Million Debt Facility to Advance Neurodegenerative Disease TreatmentsMNA: Dec 11th, 2024, 04:10Length: 4249 Biomednewsbreaks - Clene Inc. (NASDAQ: CLNN) Advances CNM-Au8 In ALS With FDA Guidance On Accelerated Approval PathwayMNA: Dec 11th, 2024, 02:33Length: 4249 Biomednewsbreaks - Clene Inc. (NASDAQ: CLNN) Advances CNM-Au8 In ALS With FDA Guidance On Accelerated Approval PathwayMNA: Dec 11th, 2024, 00:44Length: 4249 Biomednewsbreaks - Clene Inc. (NASDAQ: CLNN) Advances CNM-Au8 In ALS With FDA Guidance On Accelerated Approval PathwayNNW: Dec 10th, 2024, 13:28Length: 5718 BioMedNewsBreaks -- Clene Inc. (NASDAQ: CLNN) Advances CNM-Au8 in ALS with FDA Guidance on Accelerated Approval Pathway
Market data delivered to TradingCharts.com, Inc. by Barchart.com.
Although it is believed that information provided is accurate, no guarantee is made.
|
